The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Jeong Jin-hyeok is a lead specialist in drug product at Samsung Biologics.

Articles

Aseptic techniques must be practiced throughout all stages of biologics production.

Aseptic Processes Safeguard Biologics

Blake Willias is vice-president of Operations at G-CON Manufacturing.

Dennis Power is vice-president of Business Development at G-CON Manufacturing.

Contextualizing what type of flexibility is needed is paramount when considering cleanroom design.

The Quest for Cleanroom Flexibility

Jennifer Markarian is a contributing editor for 

Machine learning provides real-time data for process control of high-shear wet granulation.

AI Algorithms Find Use in Pharma Equipment

Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.

Life Biosciences, Forge Biologics Partner for Manufacturing to Advance Gene Therapies

Engineering Research Center for Structured Organic Particulate Systems (ERC-SOPS), Department of Chemical and Biochemical Engineering, Rutgers, The State University of New Jersey, Piscataway, NJ 08854, USA.

Advanced continuous manufacturing with modular components is emerging as a preferred platform to produce APIs.

Advanced Continuous Manufacturing of Drugs

Dr. Ulrike Lemke, Head of Sterile Fill Finish at Recipharm, sat down with Grant Playter, associate editor, to discuss drug delivery forms.

Exploring Drug Storage, Drug Dosage, and the Supply Chain with Ulrike Lemke (DCAT Week)

Feliza Mirasol is the science editor for 

The new partnership between Sandoz, a Novartis division, and Just – Evotec Biologics will aim to develop and manufacture multiple biosimilars.

Sandoz and Just – Evotec Biologics Form Biosimilars Pact

According to a press release, SGS has doubled its capacity for nitrosamine testing for North American customers.

SGS Expands Nitrosamine Testing Capacity

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions 

Chris Spivey is director of Industry Relations and Strategic Partnership, MJH Life Sciences.

Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.